Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Rua Alfredo Allen, 208 4200-135 Porto, Portugal
Phone: +351 226 074 900
Email: info@i3s.up.pt
Immunology, Cancer & Glycomedicine
WHAT WE DO
Our Lab
Our group works at the interface of immunology, cancer and glycobiology, using a combination of in vitro, ex vivo and in vivo approaches.
Publications
The group’s research has been published in a number of high-impact publications over the years.
Research Topics
The group’s research explores several topics related to the impact of glycans on inflammation, autoimmunity and cancer.
OUR RESEARCH
OUR GROUP MAIN LINES OF RESEARCH:
Immune response
The exploitation of the cellular and molecular mechanisms by which glycans contribute to amplify immune response in chronic inflammation and autoimmunity.
OUR GROUP MAIN LINES OF RESEARCH:
Cancer glycosignatures
The investigation of how cancer-specific glycosignatures regulate the immunological networks in cancer.
HIGHLIGHTS
Pinho’s Lab Guilherme Faria Awarded EACR Travel Grant
Guilherme Faria, a PhD student at Pinho’s Lab, has been awarded an EACR Travel Grant to attend the EACR 2026 Congress.
Pinho’s Lab Receives an honourable mention in the Basinnov Innovation Awards 2026
Pinho’s Lab has received an honourable mention in the Basinnov Innovation Awards 2026, awarded to Catarina Azevedo, to the project GLY-CART — “Glycoengineered CAR-T Cells: a new strategy to Break Solid Tumor Resistance”.
Uncovering early immune drivers of IBD: Pinho’s Lab receives ECCO Grant
Inês Alves has recently been awarded with an ECCO Grant!
This work will contribute to the discovery of novel mechanism and therapeutic targets at the interface of health-to-disease transition.